Work

Tumor Therapy: In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response (Adv. Mater. 31/2021)

Year: 2021

Type: article

Source: Advanced Materials

DOI: 10.1002/adma.202170244

Authors: Worapol Ngamcherdtrakul, Moataz Reda, Molly A. Nelson, Ruijie Wang, Husam Y. Zaidan, Daniel S. Bejan, Ngoc Ha Hoang, Ryan S. Lane, Shiuh‐Wen Luoh, Sancy A. Leachman, Gordon B. Mills, Joe W. Gray, Amanda W. Lund, Wassana Yantasee

Institutions: PDX Pharmaceuticals (United States), Oregon Health & Science University, Portland VA Medical Center, VA Portland Health Care System, OHSU Knight Cancer Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3187869447

FWCI:

Cites:

Cited by:

Related to: 10